| |
 |
Medical devices for the surgical treatment of spinal disorders (NASDAQ: ATEC) |
Alphatec Spine
Carlsbad, CA |
|
 |
Biopharmaceutical development for cardiovascular diseases (NASDAQ: AMRN) |
Amarin
Dublin, Ireland |
|
 |
Implantable medical device development for aortic aneurysms |
Aptus Endosystems
Sunnyvale, CA |
|
 |
Implantable medical device development for glaucoma |
AqueSys
Irvine, CA |
|
 |
Biopharmaceutical development for pain management (NASDAQ: CADX) |
Cadence Pharmaceuticals
San Diego, CA |
|
 |
Cardiovascular diagnostics that improve patient care and reduce payor costs |
CardioDx
Palo Alto, CA |
|
 |
Biopharmaceutical development for pulmonary drug delivery |
Civitas Therapeutics
Chelsea, MA |
|
 |
Biopharmaceutical development for severe psychiatric and metabolic diseases (NASDAQ: CORT) |
Corcept Therapeutics
Menlo Park, CA |
|
 |
Specialty pharmaceutical development for neonatal and pediatric disorders |
InfaCare Pharmaceutical
Trevose, PA |
|
 |
Specialty pharmaceutical development and commercialization for neurological and psychiatric conditions (NASDAQ: JAZZ) |
Jazz Pharmaceuticals
Palo Alto, CA |
|
 |
Procedural medical devices for home and in-center hemodialysis (NASDAQ: NXTM) |
NxStage Medical
Lawrence, MA |
|
 |
Novel spectacle lens technology for improved vision correction |
PixelOptics
Roanoke, VA |
|
 |
Diagnostic tools and services to improve treatment outcomes for cancer patients |
Precision Therapeutics
Pittsburgh, PA |
|
 |
Procedural medical devices for skin tightening, contouring and resurfacing (NASDAQ: SLTM) |
Solta Medical
Hayward, CA |
|
 |
Procedural medical device development for managing body temperature of critically ill or surgical patients |
Velomedix
Menlo Park, CA |
| |
 |
Specialty pharmaceutical development and commercialization for pain management |
Xanodyne Pharmaceuticals
Newport, KY |
| |
